Second Primary Malignant Tumours in Patients with Renal Cell Carcinoma
Journal Title: The Bulletin of Urooncology - Year 2021, Vol 20, Issue 1
Abstract
Objective: The primary aim of our study is to establish the frequency and clinicopathological features of seconder primary malignant tumours (SPMTs) in cases with renal cell carcinoma (RCC). Materials and Methods: Pathology reports of 1129 RCC cases were checked retrospectively, and 70 RCC cases with SPMTs were included in the study. One patient had two and the other had three different SPMTs, so the total number of SPMTs was 73. According to occurrence times of SPMTs, the cases were classified as the antecedent, synchronous, subsequent and unknown. The first three groups were compared according to their clinicopathological features. Results: The incidence of SPMTs with RCC in our study was 6.2% and lower than that reported by many other studies. The most common SPMTs were gastrointestinal, breast, prostate, lung, thyroid carcinomas and haematolymphoid malignancies. Sixty-two per cent of SPMTs were developed as synchronous and subsequent. There was no statistically significant difference among groups regarding age, histological subtype and RCC size. Male patients had a higher percentage in the synchronous group. In all groups, the most common RCC subtype was clear cell carcinoma. The RCC subtype in cases with multiple SPMTs was papillary. The prostatic adenocarcinoma rate was remarkable in males with papillary type RCC. Conclusion: RCC can coexist with secondary malignancies. Therefore, when a new tumour appears in a patient with RCC in clinical follow-up, it is appropriate to evaluate that tumour histopathologically or cytopathologically regarding SPMT before accepting it as a metastatic spread.
Authors and Affiliations
Hale Demir, Özden Yülek, Ertuğrul Oruç, Buğra Taygun Gülle, Deniz Nur Demir, Çetin Demirdağ, Haydar Durak, İclal Gürses, Nesrin Uygun
Keywords
Related Articles
- EP ID EP693536
- DOI 10.4274/uob.galenos.2020.1785
- Views 117
- Downloads 0
Changes in Metastatic Castration Sensitive Prostate Cancer
Prostate cancer is the second most common cancer in men worldwide, with approximately 1,276,106 new patients and 358,989 new deaths. Metastatic castrationsensitive prostate cancer may be de novo metastatic, but also it m...
Effect of Primary Testicular Tumor Localization on Prognosis and Survival of Non-seminomatous Testis Cancer Patients
Objective: Unlike left testicular vein, right testicular vein drains into inferior vena cava. Consequently, the systemic spread of testicular cancers in each side is expected to differ based on the vascular structures of...
Comparison of Prostate Cancer Detection Rates of Cognitive Fusion-targeted Biopsy and Standard Transrectal Ultrasound-guided Biopsy
Objective: The aim of this study is to investigate whether there is a difference between standard prostate needle biopsies and cognitive fusion prostate biopsies (classical 12-core plus 2 cognitive lesions) for any prost...
The Key Steps in Robotic Radical Prostatectomy
No summary
Preoperative and Postoperative Gleason Score Correlation of Patients Who Underwent Radical Prostatectomy
Objective: We aimed to report the consistency between transrectal needle biopsy (TRNB) Gleason scores (GSs) and prostatectomy specimen GSs based on upgrading and downgrading rates. Materials and Methods: Data of patient...